Back لقاح الناقلات Arabic Vaccí de vector víric Catalan Virová vektorová vakcína Czech Vacuna de vector viral Spanish واکسن ناقل ویروسی Persian Allurar rigakafin kwayar cuta Hausa ウイルスベクターワクチン Japanese 바이러스 벡터 백신 Korean വൈറൽ വെക്റ്റർ വാക്സിൻ Malayalam Virale-vectorvaccin Dutch
A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, to elicit an immune response.[1] As of April 2021[update], six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans.[2]
- ^ Sasso E, D'Alise AM, Zambrano N, Scarselli E, Folgori A, Nicosia A (August 2020). "New viral vectors for infectious diseases and cancer". Seminars in Immunology. 50: 101430. doi:10.1016/j.smim.2020.101430. PMID 33262065. S2CID 227251541.
- ^ Wang F, Qin Z, Lu H, He S, Luo J, Jin C, Song X (July 2019). "Clinical translation of gene medicine". The Journal of Gene Medicine. 21 (7): e3108. doi:10.1002/jgm.3108. PMID 31246328. S2CID 195695440.